These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 2377176)

  • 1. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
    Hawkins PN; Lavender JP; Pepys MB
    N Engl J Med; 1990 Aug; 323(8):508-13. PubMed ID: 2377176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
    J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis.
    Hachulla E; Maulin L; Deveaux M; Facon T; Blétry O; Vanhille P; Wechsler B; Godeau P; Levesque H; Hatron PY; Huglo D; Devulder B; Marchandise X
    Am J Med; 1996 Jul; 101(1):77-87. PubMed ID: 8686719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Localized amyloidosis': 123I-labelled SAP component scintigraphy and labial salivary gland biopsy.
    Maulin L; Hachulla E; Deveaux M; Janin A; Wechsler B; Godeau P; Rousset H; Barrier JH; Hatron PY; Devulder B; Huglo D; Marchandise X
    QJM; 1997 Jan; 90(1):45-50. PubMed ID: 9093588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
    Hazenberg BP; van Rijswijk MH; Piers DA; Lub-de Hooge MN; Vellenga E; Haagsma EB; Hawkins PN; Jager PL
    Am J Med; 2006 Apr; 119(4):355.e15-24. PubMed ID: 16564782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
    Saïle R; Deveaux M; Hachulla E; Descamps J; Duquesnoy B; Marchandise X
    Eur J Nucl Med; 1993 Feb; 20(2):130-7. PubMed ID: 8440269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis.
    Hazenberg BP; van Rijswijk MH; Lub-de Hooge MN; Vellenga E; Haagsma EB; Posthumus MD; Jager PL
    J Nucl Med; 2007 Jun; 48(6):865-72. PubMed ID: 17504868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component.
    Nelson SR; Hawkins PN; Richardson S; Lavender JP; Sethi D; Gower PE; Pugh CW; Winearls CG; Oliver DO; Pepys MB
    Lancet; 1991 Aug; 338(8763):335-9. PubMed ID: 1677697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
    Hawkins PN; Myers MJ; Epenetos AA; Caspi D; Pepys MB
    J Exp Med; 1988 Mar; 167(3):903-13. PubMed ID: 3351437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of primary amyloidosis using scintigraphy with the serum amyloid P component: from diagnosis to prognosis].
    Maulin L; Hachulla E; Facon T; Deveaux M; Blétry O; Vanhille P; Wechsler B; Godeau P; Levesque H; Marchandise W
    Rev Med Interne; 1993; 14(10):962. PubMed ID: 8009058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component.
    Hawkins PN; Myers MJ; Lavender JP; Pepys MB
    Lancet; 1988 Jun; 1(8600):1413-8. PubMed ID: 2898580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Localized or systemic amyloidosis? Value and limitations of Iodine-123 labelled amyloid P component scintigraphy, role of biopsy of minor salivary glands].
    Hachulla E; Wechsler B; Deveaux M; Godeau P; Hatron PY; Devulder B; Janin A; Marchandise X
    Rev Med Interne; 1994 Mar; 15(3):182-5. PubMed ID: 8059132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.
    Lovat LB; Persey MR; Madhoo S; Pepys MB; Hawkins PN
    Gut; 1998 May; 42(5):727-34. PubMed ID: 9659172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
    Flipo RM; Deveaux M; Duneton O; Foissac-Gegoux P; Dumont A; Duquesnoy B; Marchandise X
    Nephrologie; 1995; 16(6):419-25. PubMed ID: 8524449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis.
    Hawkins PN; Aprile C; Capri G; Viganò L; Munzone E; Gianni L; Pepys MB; Merlini G
    Eur J Nucl Med; 1998 Jul; 25(7):701-8. PubMed ID: 9662591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis.
    Hawkins PN; Richardson S; Vigushin DM; David J; Kelsey CR; Gray RE; Hall MA; Woo P; Lavender JP; Pepys MB
    Arthritis Rheum; 1993 Jun; 36(6):842-51. PubMed ID: 8507227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.
    Hawkins PN; Richardson S; MacSweeney JE; King AD; Vigushin DM; Lavender JP; Pepys MB
    Q J Med; 1993 Jun; 86(6):365-74. PubMed ID: 8171184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and monitoring of amyloidosis.
    Hawkins PN
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):635-59. PubMed ID: 7954867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 99mTc-MAMA-chrysamine G as an in vivo probe for amyloidosis.
    Dezutter NA; Landman WJ; Jager PL; de Groot TJ; Dupont PJ; Tooten PC; Zekarias B; Gruys E; Verbruggen AM
    Amyloid; 2001 Sep; 8(3):202-14. PubMed ID: 11676297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
    Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.